1Zhou H,Deng J,Li J,et al.Study of the relationship between cigarette smoking,alcohol drinking and cognitive impairment among elderly people in China.Age Ageing,2003,32:205.
2Nyenhuis DL,Gorelick PB.Vascular dementia:a contemporary review of epidemiology,diagnosis,prevention,and treatment.J Am Geriatr Soc,1998,46:1437.
9Thomas NJ,Morris CM,Scaravilli F,et al.Hereditary vascular dementia linked to notch 3 mutations.CADASIL in British families.Ann N Y Acad Sci,2000,903:293.
10Souza DR,de Godoy MR,Hotta J,et al.Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.Braz J Med Biol Res,2003,36:919.
3Decoo DA, De Reuck JL, Goethals PP, et al. Multiple lacunes and dementia: A Comparative computed and positron emission tomography study [ M ]. International stroke society Second World congress of stroke, 1992.109.
4Meyer JS, Judd BW, Tawaklna T, et al. Improved cognition after control of risk factors for multi-infarct dementia [ J ]. JAMA, 1986,256 (16): 2203-2209.
5Gouliaev AH, Senning A, Piracetam and other structurally related nootropics[ J]. Brain Res Brain Res Rev, 1994,19(2): 180-222.
6Villardita C,Grioli S,Lomeo C.Clinical studies with oxiracetam in patients with dementia of mild to moderate degree[ J]. Neuropsychobilogy, 1992,25(1) :24.
7Schneider LS, Olin JT. Overview of clinical trials of hydergine in dementia[ J ]. Arch Neurol, 1994,51 (8): 787-798.
8Le-Bars PL, Katz MM, Bennan N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia[ J ]. JAMA, 1997,278(16): 1327-1332.
9Sakurada T,Alufuzoff I,Winblad B, et al .Substance P-like immunoreactvity, choline acetyltran sferase activity and cholinergic muscarinic receptors in Alzheimer's disease and Multi-infarct dementia [ J]. Brain Res, 1990,521 (3) :329.
10WhitehousePJ RossorM.Global drug development in dementia.基础医学与临床,1998,18(5):322-328.
